VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, cardiometabolic disease and exposomics. Contact us to discuss how you can add breath research to your own research.
There are 5 results matching your search criteriaClear all filters
SCFAs on breath could help detect esophageal-gastric cancer earlier
Cancer, Esophogastric Cancer
FAIMS could be a non-invasive solution for pancreatic cancer detection
Cancer, Pancreatic Cancer